Cargando…
Understanding the Risks of Immunosuppression Reduction for Active COVID-19 Infection
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916827/ https://www.ncbi.nlm.nih.gov/pubmed/35309736 http://dx.doi.org/10.1016/j.ekir.2022.03.005 |
_version_ | 1784668396451790848 |
---|---|
author | Meena, Priti Crew, R. John |
author_facet | Meena, Priti Crew, R. John |
author_sort | Meena, Priti |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8916827 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-89168272022-03-14 Understanding the Risks of Immunosuppression Reduction for Active COVID-19 Infection Meena, Priti Crew, R. John Kidney Int Rep Commentary Elsevier 2022-03-12 /pmc/articles/PMC8916827/ /pubmed/35309736 http://dx.doi.org/10.1016/j.ekir.2022.03.005 Text en © 2022 International Society of Nephrology. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Commentary Meena, Priti Crew, R. John Understanding the Risks of Immunosuppression Reduction for Active COVID-19 Infection |
title | Understanding the Risks of Immunosuppression Reduction for Active COVID-19 Infection |
title_full | Understanding the Risks of Immunosuppression Reduction for Active COVID-19 Infection |
title_fullStr | Understanding the Risks of Immunosuppression Reduction for Active COVID-19 Infection |
title_full_unstemmed | Understanding the Risks of Immunosuppression Reduction for Active COVID-19 Infection |
title_short | Understanding the Risks of Immunosuppression Reduction for Active COVID-19 Infection |
title_sort | understanding the risks of immunosuppression reduction for active covid-19 infection |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916827/ https://www.ncbi.nlm.nih.gov/pubmed/35309736 http://dx.doi.org/10.1016/j.ekir.2022.03.005 |
work_keys_str_mv | AT meenapriti understandingtherisksofimmunosuppressionreductionforactivecovid19infection AT crewrjohn understandingtherisksofimmunosuppressionreductionforactivecovid19infection |